Accessibility Menu
 

CalciMedica

(NASDAQ) CALC

Current Price$0.68
Market Cap$9.09M
Since IPO (2023)-91%
5 Year-99%
1 Year-73%
1 Month+5%

CalciMedica Financials at a Glance

Market Cap

$9.09M

Revenue (TTM)

$0.00

Net Income (TTM)

$29.56M

EPS (TTM)

$-1.97

P/E Ratio

-0.29

Dividend

$0.00

Beta (Volatility)

0.48 (Low)

Price

$0.68

Volume

393,818

Open

$0.72

Previous Close

$0.58

Daily Range

$0.58 - $0.73

52-Week Range

$0.46 - $7.20

CALC News

No articles available.

CALC: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About CalciMedica

Industry

Pharmaceuticals

Employees

16

CEO

Rachel Anne Leheny, PhD

Headquarters

La Jolla, CA 92037, US

CALC Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-761%

Return on Capital

-2%

Return on Assets

-2%

Earnings Yield

-3.45%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$9.09M

Shares Outstanding

15.74M

Volume

393.82K

Short Interest

0.00%

Avg. Volume

1.24M

Financials (TTM)

Gross Profit

$46.00K

Operating Income

$23.12M

EBITDA

$23.12M

Operating Cash Flow

$21.18M

Capital Expenditure

$28.00K

Free Cash Flow

$21.21M

Cash & ST Invst.

$13.02M

Total Debt

$9.70M

CalciMedica Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$5.00K

+64.3%

Gross Margin

0.00%

N/A

Market Cap

$9.09M

N/A

Market Cap/Employee

$649.55K

N/A

Employees

14

N/A

Net Income

$10.76M

-152.7%

EBITDA

$4.38M

-3.3%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$3.32M

-82.2%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$8.45M

N/A

Short Term Debt

$1.25M

N/A

Return on Assets

-2.18%

N/A

Return on Invested Capital

-2.36%

N/A

Free Cash Flow

$4.86M

+2.3%

Operating Cash Flow

$4.85M

+2.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RVPHReviva Pharmaceuticals Holdings, Inc.
$0.80-4.01%
LTRNLantern Pharma Inc.
$2.13-1.39%
PDSBPDS Biotechnology Corporation
$0.57-8.65%
TVRDTvardi Therapeutics, Inc.
$3.52-4.35%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
INFYInfosys
$13.12+0.01%

Questions About CALC

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.